Skip to main content
. 2021 Dec 9;107(4):e1390–e1401. doi: 10.1210/clinem/dgab882

Figure 3.

Figure 3.

(A) Unadjusted fracture risk estimation by HbA1c mean in observational period, and HbA1c mean in follow-up period (up to first fracture incidence if applicable). HbA1c measured in the same period as fracture incidences underestimates the risk of all fractures. N = 101 575 for mean HbA1c follow-up 6%-9%; N = 11 266 for mean HbA1c follow-up 9%+. (B) Unadjusted fracture risk estimation when stratified by high/low SD within each mean HbA1c level. The fracture risk is not statistically different when stratified by HbA1c SD. N = 74 418 for mean HbA1c 6%-9%, SD <= 0.5%; N = 30 748 for mean HbA1c 6%-9%, SD > 0.5%; N = 1968 for mean HbA1c 9%+, SD <= 0.5%; N = 7522 for mean HbA1c 9%+, SD > 0.5%.